Comments
Loading...

Dare Bioscience Analyst Ratings

DARENASDAQ
Logo brought to you by Benzinga Data
$2.90
At close: May 15, 6:23 PM EDT
$2.80
-0.10-3.45%
Pre-Market: May 15, 6:23 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$13.00
Lowest Price Target1
$3.00
Consensus Price Target1
$8.50

Dare Bioscience Analyst Ratings and Price Targets | NASDAQ:DARE | Benzinga

Dare Bioscience Inc has a consensus price target of $8.5 based on the ratings of 5 analysts. The high is $13 issued by Jones Trading on August 16, 2024. The low is $3 issued by Brookline Capital on May 15, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on April 1, 2025, December 17, 2024, and November 15, 2024, respectively. With an average price target of $12 between HC Wainwright & Co., there's an implied 328.57% upside for Dare Bioscience Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Dec 24
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Jones Trading
Brookline Capital
JonesTrading

1calculated from analyst ratings

Analyst Ratings for Dare Bioscience

Buy NowGet Alert
04/01/2025Buy Now328.57%HC Wainwright & Co.
Douglas Tsao51%
$12 → $12ReiteratesBuy → BuyGet Alert
12/17/2024Buy Now328.57%HC Wainwright & Co.
Douglas Tsao51%
$12 → $12ReiteratesBuy → BuyGet Alert
11/15/2024Buy Now328.57%HC Wainwright & Co.
Douglas Tsao51%
$12 → $12ReiteratesBuy → BuyGet Alert
10/24/2024Buy Now328.57%HC Wainwright & Co.
Douglas Tsao51%
$12 → $12ReiteratesBuy → BuyGet Alert
08/16/2024Buy Now364.29%Jones Trading
Catherine Novack32%
$5 → $13MaintainsBuyGet Alert
08/14/2024Buy NowMaxim Group
Caroline Palomeque59%
DowngradeBuy → HoldGet Alert
05/15/2024Buy Now114.29%HC Wainwright & Co.
Douglas Tsao51%
$6 → $6ReiteratesBuy → BuyGet Alert
05/15/2024Buy Now7.14%Brookline Capital
Kemp Dolliver27%
→ $3UpgradeHold → BuyGet Alert
05/01/2024Buy Now114.29%HC Wainwright & Co.
Douglas Tsao51%
$6 → $6ReiteratesBuy → BuyGet Alert
04/17/2024Buy NowBrookline Capital
Kemp Dolliver27%
DowngradeBuy → HoldGet Alert
04/01/2024Buy Now114.29%HC Wainwright & Co.
Douglas Tsao51%
$6 → $6ReiteratesBuy → BuyGet Alert
11/10/2023Buy Now114.29%HC Wainwright & Co.
Douglas Tsao51%
$7 → $6MaintainsBuyGet Alert
08/11/2023Buy Now150%HC Wainwright & Co.
Douglas Tsao51%
→ $7ReiteratesBuy → BuyGet Alert
07/13/2023Buy Now150%HC Wainwright & Co.
Douglas Tsao51%
→ $7ReiteratesBuy → BuyGet Alert
06/06/2023Buy Now150%HC Wainwright & Co.
Douglas Tsao51%
→ $7Reiterates → BuyGet Alert
05/22/2023Buy Now150%HC Wainwright & Co.
Douglas Tsao51%
→ $7ReiteratesBuy → BuyGet Alert
05/12/2023Buy Now150%HC Wainwright & Co.
Douglas Tsao51%
→ $7ReiteratesBuy → BuyGet Alert
03/31/2023Buy Now150%HC Wainwright & Co.
Douglas Tsao51%
→ $7Reiterates → BuyGet Alert
12/13/2022Buy Now150%HC Wainwright & Co.
Douglas Tsao51%
$6 → $7MaintainsBuyGet Alert
12/01/2022Buy Now114.29%JonesTrading
Catherine Novack32%
→ $6Initiates → BuyGet Alert

FAQ

Q

What is the target price for Dare Bioscience (DARE) stock?

A

The latest price target for Dare Bioscience (NASDAQ:DARE) was reported by HC Wainwright & Co. on April 1, 2025. The analyst firm set a price target for $12.00 expecting DARE to rise to within 12 months (a possible 328.57% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Dare Bioscience (DARE)?

A

The latest analyst rating for Dare Bioscience (NASDAQ:DARE) was provided by HC Wainwright & Co., and Dare Bioscience reiterated their buy rating.

Q

When was the last upgrade for Dare Bioscience (DARE)?

A

The last upgrade for Dare Bioscience Inc happened on May 15, 2024 when Brookline Capital raised their price target to $3. Brookline Capital previously had a hold for Dare Bioscience Inc.

Q

When was the last downgrade for Dare Bioscience (DARE)?

A

The last downgrade for Dare Bioscience Inc happened on August 14, 2024 when Maxim Group changed their price target from N/A to N/A for Dare Bioscience Inc.

Q

When is the next analyst rating going to be posted or updated for Dare Bioscience (DARE)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dare Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dare Bioscience was filed on April 1, 2025 so you should expect the next rating to be made available sometime around April 1, 2026.

Q

Is the Analyst Rating Dare Bioscience (DARE) correct?

A

While ratings are subjective and will change, the latest Dare Bioscience (DARE) rating was a reiterated with a price target of $12.00 to $12.00. The current price Dare Bioscience (DARE) is trading at is $2.80, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch